Opportunities in the lung cancer antibody drug conjugates market include developing specific, low-toxicity therapies using ADCs, capitalizing on technology platforms like DXd, leveraging collaboration ...

These pivotal studies investigated AstraZeneca and Daiichi Sankyo’s Enhertu, a human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate with a topoisomerase II-targeting ...

The multicentre, randomised trial was conducted in China, but Sichuan-Kelun and Merck & Co will commercialise sac-TMT in ...

(“Sintana ”) and Challenger Energy Group plc (“Challenger ”) earlier today, we have reached another milestone associated with our proposed all-share acquisition of Challenger. A Scheme Document in ...

Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its ...

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat ...

Conference Call and Webcast Presentation The FibroGen management team will host a conference call and webcast presentation to discuss the financial results and provide a business update. A live Q&A ...

Zocilurtatug pelitecan shows promising results as a DLL3-targeted therapy for small cell lung cancer, with high response rates and ongoing trials.

Gary Hattersley, chief scientific officer at Nuvation Bio ( NUVB +1.36%), exercised and immediately sold 100,000 shares of Class A common stock in an open-market derivative transaction on October 27, ...

A variety of vaccines in the U.S. childhood vaccination schedule help to protect kids against meningitis.

Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemons ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended September 30, 2025, ...